Home › Funds › Triata Capital Ltd › LEGN

Triata Capital Ltd position in LEGN

LEGEND BIOTECH CORP · Health Care

Triata Capital Ltd reported holding 989,014 shares of LEGN (LEGEND BIOTECH CORP) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 3.70% of its reported portfolio and ranking #8 among its reported holdings. Triata Capital Ltd has disclosed LEGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)989.01K sh
Reported value held$19.67M
Portfolio Weight3.70%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Triata Capital Ltd's LEGN position evolved

Triata Capital Ltd first disclosed a stake in LEGN in Q2 2025 at 107,500 shares (US$3.8M). The position peaked in Q3 2026 at 989,014 shares, worth US$19.7M. Across 6 filings, Triata Capital Ltd increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 989,014 shares valued at US$19.7M — an increase of 359,100 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2025 (shares fell 17% over the following quarter), a 149% increase in Q1 2026 (shares rose 60% over the following quarter), a 57% increase in Q3 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 107.50K $3.82M New
Q3 2025 161.80K $5.28M Add
Q4 2025 252.60K $5.49M Add
Q1 2026 629.91K $11.40M Add
Q2 2026 629.91K $18.19M Hold
Q3 2026 989.01K $19.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LEGN and 13F data

LEGN (LEGEND BIOTECH CORP) is a Health Care company. 15 other funds we track also report a position in LEGN — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$235.0M), MONTANOVA CAPITAL, LLC (US$204.2M), Hillhouse Capital (HHLR Advisors) (US$172.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LEGN

All LEGN fund holders →

FAQ

How long has Triata Capital Ltd held LEGN?

Triata Capital Ltd has disclosed LEGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Triata Capital Ltd's current position in LEGN?

As of Q3 2026, Triata Capital Ltd holds 989.01K shares of LEGN (LEGEND BIOTECH CORP), valued at $19.67M, representing 3.70% of its reported portfolio and ranking #8.

Has Triata Capital Ltd been buying or selling LEGN?

In the latest 13F filing (Q3 2026), Triata Capital Ltd increased its position in LEGN. The position peaked in Q3 2026 at 989.01K shares.

Which other funds hold LEGN?

Other major institutional holders of LEGN include DEERFIELD MANAGEMENT COMPANY, L.P., MONTANOVA CAPITAL, LLC, Hillhouse Capital (HHLR Advisors), among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.